JP2011523950A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523950A5
JP2011523950A5 JP2011511955A JP2011511955A JP2011523950A5 JP 2011523950 A5 JP2011523950 A5 JP 2011523950A5 JP 2011511955 A JP2011511955 A JP 2011511955A JP 2011511955 A JP2011511955 A JP 2011511955A JP 2011523950 A5 JP2011523950 A5 JP 2011523950A5
Authority
JP
Japan
Prior art keywords
lipolysis
preparation according
enhancing
paeoniflorin
enhancement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011511955A
Other languages
English (en)
Japanese (ja)
Other versions
JP5507549B2 (ja
JP2011523950A (ja
Filing date
Publication date
Priority claimed from US12/126,246 external-priority patent/US7943187B2/en
Application filed filed Critical
Publication of JP2011523950A publication Critical patent/JP2011523950A/ja
Publication of JP2011523950A5 publication Critical patent/JP2011523950A5/ja
Application granted granted Critical
Publication of JP5507549B2 publication Critical patent/JP5507549B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011511955A 2008-05-23 2009-05-25 脂肪低下のためのペオニフロリン製剤およびその使用 Expired - Fee Related JP5507549B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/126,246 US7943187B2 (en) 2008-05-23 2008-05-23 Paeoniflorin preparations and uses thereof for fat reduction
US12/126,246 2008-05-23
PCT/CN2009/000569 WO2010127470A1 (en) 2008-05-23 2009-05-25 Paeoniflorin preparations and uses thereof for fat reduction

Publications (3)

Publication Number Publication Date
JP2011523950A JP2011523950A (ja) 2011-08-25
JP2011523950A5 true JP2011523950A5 (OSRAM) 2013-05-23
JP5507549B2 JP5507549B2 (ja) 2014-05-28

Family

ID=41342622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511955A Expired - Fee Related JP5507549B2 (ja) 2008-05-23 2009-05-25 脂肪低下のためのペオニフロリン製剤およびその使用

Country Status (9)

Country Link
US (4) US7943187B2 (OSRAM)
EP (1) EP2300018B1 (OSRAM)
JP (1) JP5507549B2 (OSRAM)
KR (1) KR101656536B1 (OSRAM)
CN (1) CN102170888B (OSRAM)
AU (2) AU2009345773A1 (OSRAM)
CA (1) CA2725972A1 (OSRAM)
DK (1) DK2300018T3 (OSRAM)
WO (1) WO2010127470A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943187B2 (en) * 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20130012840A1 (en) * 2010-03-23 2013-01-10 Real Aesthetics Ltd. System and method for accelerating the relative proportion of fat catabolism
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
WO2015061280A1 (en) 2013-10-21 2015-04-30 Alevere Medical Corporation Fused heterocyclic organic compounds, pharmaceutical compositions, and medical uses thereof
WO2017079700A1 (en) * 2015-11-04 2017-05-11 Kythera Biopharmaceuticals, Inc. Treatments of accumulated fat with deoxycholic acid and salts thereof
WO2019156213A1 (ja) 2018-02-09 2019-08-15 琥珀バイオテクノロジー株式会社 グリセロール放出促進剤
KR102392292B1 (ko) 2021-07-21 2022-05-03 중앙대학교 산학협력단 페오니플로린을 포함하는 악액질 및 근손실 예방 또는 치료용 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6485990A (en) * 1987-09-28 1989-03-30 Tsumura & Co Antihypertestoeronemia agent
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US5919621A (en) 1991-10-24 1999-07-06 Brown; David B. Methods for diagnosing human male infertility
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5480772A (en) 1993-02-03 1996-01-02 Brandeis University In vitro activation of a nucleus
FR2717382B1 (fr) * 1994-03-21 1996-06-07 Fabre Pierre Cosmetique Extraits de Paeonia Lactiflora titré en paeoniflorine utiles en cosmétologie dans le traitement capillaire.
PE17897A1 (es) * 1995-02-17 1997-06-12 Lilly Co Eli Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
EP1021191B1 (de) 1997-10-08 2002-06-05 Genesiscosmetics Rights & Licenses Company Limited Straffung und/oder verkleinerung von fettzellen-haltigen körperpartien
US6638064B1 (en) * 2000-06-07 2003-10-28 Robert Scott Nance Flexible endodontic syringe
ES2333849T3 (es) * 2001-04-20 2010-03-02 Alza Corporation Disposicion de microsalientes que presenta un revestimiento que contiene un agente beneficioso.
CN2560367Y (zh) * 2001-08-30 2003-07-16 夏勤 适于喉部和气管滴入药物的针头
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
JP2004217583A (ja) * 2003-01-16 2004-08-05 Naris Cosmetics Co Ltd 痩身用皮膚外用剤
US20040191330A1 (en) * 2003-03-31 2004-09-30 Keefe Candace R. Daily skin care regimen
CN1555806A (zh) * 2003-12-31 2004-12-22 昆明同持医药研究有限公司 一种芍药甙注射剂及其制备方法和应用
US20080194496A1 (en) * 2004-05-10 2008-08-14 Lg Household & Health Care Ltd. Skin Aging Treatment Comprising Paeoniflorin
KR100769580B1 (ko) * 2005-03-07 2007-10-23 주식회사 엘지생활건강 자외선에 의한 피부 ｄｎａ 손상 방지제
KR20050107649A (ko) * 2004-05-10 2005-11-15 주식회사 엘지생활건강 페오니플로린을 포함하는 피부 노화 억제용 조성물
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US7530958B2 (en) * 2004-09-24 2009-05-12 Guided Therapy Systems, Inc. Method and system for combined ultrasound treatment
JP4974533B2 (ja) * 2006-01-30 2012-07-11 富士フイルム株式会社 ジスルフィド架橋したタンパク質ナノ粒子
US20080294072A1 (en) * 2007-05-24 2008-11-27 Crutchfield Dermatology Mesotherapy with ultrasound
US7943187B2 (en) * 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction

Similar Documents

Publication Publication Date Title
EA201492021A1 (ru) Антительный состав
UA111825C2 (uk) Стабілізований препарат, що містить антитіло проти ngf
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
EA201300159A1 (ru) Использование композиции salvia miltiorrhiza в приготовлении лекарственных препаратов для вторичной профилактики ишемической болезни сердца
WO2014066468A8 (en) Stable, low viscosity antibody formulation
IL244945A0 (en) Cationic lipid, lipid formulations comprising same and use thereof in the preparation of therapeutic agents for delivering to cells
EA201492292A1 (ru) Препарат антител
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
MX2019009244A (es) FORMULACION PARA ANTICUERPO ANTI -A4ß7.
MA33023B1 (fr) Formulation d'anticorps
MY159492A (en) Solid pharmaceutical formulation with delayed release
PE20110642A1 (es) Formulaciones antifungicas topicas a base de terbinafina y compuestos similares a terbinafina y metodos de uso
EA201200850A1 (ru) Фармацевтическая композиция, содержащая олигопептиды
RU2015122023A (ru) Стабилизированная композиция пеметрекседа
EA201070835A1 (ru) Состав капсулы
WO2011056775A3 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
CO6612226A2 (es) Tableta
EA201390394A1 (ru) Никотинсодержащий состав
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
CL2008001563A1 (es) Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras.
CL2009001137A1 (es) Compuestos derivados de cicloheptanocarboniloxi-1-azonia-biciclo[2.2.2]-octano, moduladores de receptores muscarinicos; composiciones farmaceuticas; proceso de preparacion de dicha composicion; y uso en el tratamiento de una enfermedad pulmonar obstructiva cronica.
MX378056B (es) Composiciones de cuidado oral.
PE20140104A1 (es) Composiciones farmaceuticas que comprenden alisporivir
MY160218A (en) Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof